bioRxivBioengineering
Rapid spectrophotometric detection for optimized production of landomycins and characterization of their therapeutic potential
T. C. Chappell, K. G. Maiello, A. J. Tierny, K. Yanagi, J. A. Lee, K. Lee, C. R. Mace, C. S. Bennett, N. U. Nair
Abstract
Microbial derived natural products remain a major source of structurally diverse bioactive compounds and chemical scaffolds that have potential as new therapeutics to target drug resistant pathogens and cancers. In particular, genome mining has revealed the vast number of cryptic or low yield biosynthetic gene clusters in the genus Streptomyces. Here, we describe our efforts to improve yields of landomycins - angucycline family polyketides under investigation as cancer therapeutics - by a genetically modified Streptomyces cyanogenus 136. After simplifying the extraction process from S. cyanogenus cultures, we identified a wavelength at which the major landomycin products absorb in culture extracts, which we used to systematically explore culture medium compositions to improve total landomycin titers. Through correlational analysis, we simplified the culture optimization process by identifying an alternative wavelength at which culture supernatants absorb yet is representative of total landomycin titers. Using the subsequently improved sample throughput, we explored landomycin production during the culturing process to further increase landomycin yield and reduce culture time. Testing the antimicrobial activity of the isolated landomycins, we report broad inhibition of Gram-positive bacteria, inhibition of fungi by landomycinone, and broad landomycin resistance by Gram-negative bacteria that is likely mediated by exclusion of landomycins by the bacterial membrane. Finally, the anticancer activity of the isolated landomycins against A549 lung carcinoma cells agrees with previous reports on other cell lines that glycan chain length correlates with activity. Given the prevalence of natural products produced by Streptomyces, as well as the light-absorbing moieties common to bioactive natural products and their metabolic precursors, our method is relevant to improving the yields of other natural products of interest.
- organism: bacteria (other)
- assay: metabolomics
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In situ activation and heterologous production of a cryptic lantibiotic from a plant-ant derived Saccharopolyspora species
E. Vikeli, D. Widdick, … B. Wilkinson·bioRxiv·Aug 13, 2019
- High-Yield Production of Cytotoxic Actinomycin D from Endophytic Streptomyces parvulus AL036 through Nutritional Optimization
Thongchai Taechowisan, Thanaporn Chuen‐Im, … Waya S. Phutdhawong·Journal of Applied Biology & BiotechnologyPeer-reviewed·Oct 30, 2025
- Antimicrobial and Cytotoxic Lysolipins I-M Isolated from Streptomyces sp. P8-2B18
Manar M. Mahmoud, Kah Yean Lum, … Ling Ding·bioRxiv·Jun 12, 2026
- Discovery of new antibacterial accramycins from a genetic variant of the soil bacterium, Streptomyces sp. MA37
F. Maglangit, Y. Zhang, … H. Deng·bioRxiv·Sep 14, 2020
- N-acetyl-cysteinylated streptophenazines fromStreptomyces
K. Vind, S. I. Maffioli, … S. Donadio·bioRxiv·Dec 6, 2021
- A complex regulatory network governs the production of an antibiotic with unusual cell-density-dependence
H. Hindra, M. A. Elliot·bioRxiv·Dec 13, 2023